AKT1 (Prognostic Marker for Neuroendocrine Tumors) Antibody

Biorbyt

AKT1 antibody

16

Positive Control: PDGF-treated NIH/3T3 cells. HeLa cell lysates. Human pancreas or cervical carcinoma. Western Blot (1-2ug/ml);,Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined. IHC, WB

Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Monoclonal

AKT1/2784

200 ug/ml

Unconjugated

AKT1

AKT serine/threonine kinase 1

AKT; AKT1m; PKB; PKB alpha; PKB-ALPHA; PRKBA; protein kinase B alpha; proto-oncogene c-Akt; RAC; rac protein kinase alpha; RAC-ALPHA; RAC-alpha serine/threonine-protein kinase; RAC-PK-alpha; serine-threonine protein kinase; v-akt murine thymoma viral oncogene homolog 1; v-akt murine thymoma viral oncogene-like protein 1

Mouse

IgG2b

RAC-alpha serine/threonine-protein kinase

Mouse monoclonal antibody to AKT1 (Prognostic Marker for Neuroendocrine Tumors)

Human

-20°C or -80°C,2°C to 8°C

12352203